A detailed history of Ubs Group Ag transactions in Briacell Therapeutics Corp Wt stock. As of the latest transaction made, Ubs Group Ag holds 29,058 shares of BCTXW stock, worth $8,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,058
Previous 10,023 189.91%
Holding current value
$8,136
Previous $2,000 450.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.13 - $0.41 $2,474 - $7,804
19,035 Added 189.91%
29,058 $11,000
Q2 2024

Aug 13, 2024

BUY
$0.24 - $1.25 $2,405 - $12,528
10,023 New
10,023 $2,000
Q3 2023

Nov 09, 2023

BUY
$2.1 - $3.19 $298 - $452
142 New
142 $0
Q4 2022

Feb 08, 2023

SELL
$1.85 - $3.11 $2,760 - $4,640
-1,492 Reduced 50.87%
1,441 $2,000
Q3 2022

Nov 10, 2022

SELL
$2.32 - $3.85 $4,964 - $8,239
-2,140 Reduced 42.18%
2,933 $8,000
Q2 2022

Aug 10, 2022

BUY
$1.9 - $6.55 $7,478 - $25,780
3,936 Added 346.17%
5,073 $13,000
Q1 2022

May 16, 2022

BUY
$2.98 - $5.2 $3,388 - $5,912
1,137 New
1,137 $6,000
Q4 2021

Feb 14, 2022

SELL
$3.9 - $5.5 $8,119 - $11,451
-2,082 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$1.56 - $5.25 $3,247 - $10,930
2,082 New
2,082 $10,000

Others Institutions Holding BCTXW

About BRIACELL THERAPEUTICS CORP WT


  • Ticker BCTXW
More about BCTXW
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.